Trastuzumab-resistant breast cancer cells-derived tumor xenograft models exhibit distinct sensitivity to lapatinib treatment in vivo
Cited by 8
Related Papers
Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis
|Cell Death and Differentiation|2019|258
The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells
|Oncotarget|2015|24
Targeting of HER3 with Functional Cooperative miRNAs Enhances Therapeutic Activity in HER2-Overexpressing Breast Cancer Cells
|Biological Procedures Online|2018|20
HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells
|npj Precision Oncology|2023|17
RETRACTED: Ppm1b Negatively Regulates 3-Bromopyruvate Induced Necroptosis in Breast Cancer Cells
|Frontiers in Oncology|2021|2